IGM Biosciences, Inc. (IGMS)
NASDAQ: IGMS · Real-Time Price · USD
1.240
-0.040 (-3.13%)
Mar 28, 2025, 4:00 PM EDT - Market closed

IGM Biosciences Revenue

In the year 2024, IGM Biosciences had annual revenue of $2.68M with 25.77% growth. IGM Biosciences had revenue of $412.00K in the quarter ending December 31, 2024, a decrease of -36.71%.

Revenue (ttm)
$2.68M
Revenue Growth
+25.77%
P/S Ratio
28.01
Revenue / Employee
$17,980
Employees
149
Market Cap
74.12M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20242.68M549.00K25.77%
Dec 31, 20232.13M1.06M99.25%
Dec 31, 20221.07M--
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition